STAT3 and Hutchinson-Gilford progeria syndrome: These findings underscore BAR’s ability to counteract FTI-induced STAT1 hyperactivation and its unique efficacy in normalizing aberrant STAT3 signaling, particularly in tissues such as the aorta and skin, which are the most affected in HGPS.